Pharmacokinetic-Pharmacodynamic Modeling of the Antitumor Effects of SGN-CD19A, a Novel Antibody-Drug Conjugate, in Mice

被引：0
|
作者：
Zhao, Baiteng [1 ]
Stevison, Faith [1 ]
Law, Che-Leung [2 ]
Han, Tae H. [1 ]
机构：
[1] Seattle Genet Inc, Clin Pharmacol, Bothell, WA 98021 USA
[2] Seattle Genet Inc, Preclin Res, Bothell, WA 98021 USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S17 / S18
页数：2
相关论文
共 50 条
  • [21] SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
    Sutherland, May S. Kung
    Walter, Roland B.
    Jeffrey, Scott C.
    Burke, Patrick J.
    Yu, Changpu
    Kostner, Heather
    Stone, Ivan
    Ryan, Maureen C.
    Sussman, Django
    Lyon, Robert P.
    Zeng, Weiping
    Harrington, Kimberly H.
    Klussman, Kerry
    Westendorf, Lori
    Meyer, David
    Bernstein, Irwin D.
    Senter, Peter D.
    Benjamin, Dennis R.
    Drachman, Jonathan G.
    McEarchern, Julie A.
    BLOOD, 2013, 122 (08) : 1455 - 1463
  • [22] Characterization of SGN-CD123A, APotent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid Leukemia
    Li, Fu
    Sutherland, May Kung
    Yu, Changpu
    Walter, Roland B.
    Westendorf, Lori
    Valliere-Douglass, John
    Pan, Lucy
    Cronkite, Ashley
    Sussman, Django
    Klussman, Kerry
    Ulrich, Michelle
    Anderson, Martha E.
    Stone, Ivan J.
    Zeng, Weiping
    Jonas, Mechthild
    Lewis, Timothy S.
    Goswami, Maitrayee
    Wang, Sa A.
    Senter, Peter D.
    Law, Che-Leung
    Feldman, Eric J.
    Benjamin, Dennis R.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (02) : 554 - 564
  • [23] Antibody-Drug Conjugates: Pharmacokinetic/Pharmacodynamic Modeling, Preclinical Characterization, Clinical Studies, and Lessons Learned
    Hedrich, William D.
    Fandy, Tamer E.
    Ashour, Hossam M.
    Wang, Hongbing
    Hassan, Hazem E.
    CLINICAL PHARMACOKINETICS, 2018, 57 (06) : 687 - 703
  • [24] SGN-CD228A Is an Investigational CD228-Directed Antibody-Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models
    Mazahreh, Rebecca
    Mason, Marsha L.
    Gosink, John J.
    Olson, Devra J.
    Thurman, Robert
    Hale, Christopher
    Westendorf, Lori
    Pires, Thomas A.
    Leiske, Christopher I.
    Carlson, Markus
    Nguyen, Liem T.
    Cochran, Julia H.
    Okeley, Nicole M.
    Yumul, Roma
    Jin, Steven
    Stone, Ivan J.
    Sahetya, Disha
    Nesterova, Albina
    Allred, Sean
    Hensley, Kelly M.
    Hu, Rachael
    Lawrence, Robert
    Lewis, Timothy S.
    Sandall, Sharsti
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (04) : 421 - 434
  • [25] Combination of the anti-CD30-auristatin-E antibody-drug conjugate SGN-35 with chemotherapy improves antitumor activity in Hodgkin's lymphoma
    Oflazoglu, E.
    Kennedy, D.
    Sievers, E. L.
    Kissler, K. M.
    Jonas, M.
    Ihle, N. C.
    Grewal, I. S.
    Gerber, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 235 - 236
  • [26] A novel CD30-directed antibody-drug conjugate for the treatment of lymphomas
    Hamblett, Kevin J.
    Jin, Steven
    Yumul, Roma
    Chen, Yufei
    Kwon, John
    Simmons, Jessica
    Henderson, Clark
    Sun, Hao
    Schrum, Jason P.
    Lim, Andrea R.
    Bindman, Noah A.
    Canerly, Melissa
    Clarke, Astrid
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [27] The anti-CD30 antibody-drug conjugate SGN-35 is a potent therapy for the treatment of CD30+malignancies
    Barton, J
    Hamblett, K
    Cerveny, C
    Andreyka, J
    Kissler, K
    Stone, I
    Sun, M
    Senter, P
    Wahl, A
    Francisco, J
    Ihle, N
    ANNALS OF ONCOLOGY, 2005, 16 : 134 - 134
  • [28] Novel anticarcinoembryonic antigen antibody-drug conjugate has antitumor activity in the existence of soluble antigen
    Shinmi, Daisuke
    Nakano, Ryosuke
    Mitamura, Keisuke
    Suzuki-Imaizumi, Minami
    Iwano, Junko
    Isoda, Yuya
    Enokizono, Junichi
    Shiraishi, Yasuhisa
    Arakawa, Emi
    Tomizuka, Kazuma
    Masuda, Kazuhiro
    CANCER MEDICINE, 2017, 6 (04): : 798 - 808
  • [29] Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen
    Sedlik, Christine
    Heitzmann, Adele
    Viel, Sophie
    Sarkouh, Rafik Ait
    Batisse, Cornelie
    Schmidt, Frederic
    De la Rochere, Philippe
    Amzallag, Nathalie
    Osinaga, Eduardo
    Oppezzo, Pablo
    Pritsch, Otto
    Sastre-Garau, Xavier
    Hubert, Pascale
    Amigorena, Sebastian
    Piaggio, Eliane
    ONCOIMMUNOLOGY, 2016, 5 (07):
  • [30] Novel anticarcinoembryonic antigen antibody-drug conjugate has antitumor activity in the existence of soluble antigen
    Shinmi, Daisuke
    Masuda, Kazuhiro
    CANCER SCIENCE, 2018, 109 : 332 - 332
12345